🇺🇸

US SEC Filing Intelligence

· daily

S&P 500 Consumer Discretionary Sector SEC Filings — May 18, 2026

The 50 filings from the S&P 500 Consumer Discretionary sector reveal a sector in transition, marked by aggressive capital restructuring, significant insider activity, and a clear bifurcation between companies investing for growth and those facing operational headwinds. A dominant theme is the use of high-cost debt and equity-linked financing, with Wayfair issuing $400M in 7.125% notes and Faraday Future securing $70M in convertible notes, signaling elevated borrowing costs and potential dilution. Insider trading patterns are a key signal, with the CEO of Fermi Inc. ousted for cause and a proxy battle underway, while O'Reilly Automotive's board approved a $2M stock option for its executive chairman, indicating confidence. Period-over-period data shows mixed performance: Fatpipe Inc. grew revenue 17.9% YoY but saw operating cash flow turn negative, while Tofutti Brands saw sales decline 2.1% and losses widen. Capital allocation is a key differentiator, with InfuSystem announcing a $20M buyback and O'Reilly maintaining shareholder returns, contrasting with the dilutive financing at Flux Power and Profusa. The most critical development is the $1.5B MiRus investment by Boston Scientific, a bold bet on the TAVR market, while the ongoing proxy fight at Fermi Inc. and the short-term forbearance at FiscalNote highlight governance and liquidity risks. Overall, the sector shows a 'haves and have-nots' dynamic, where strong balance sheets are being used for strategic M&A and buybacks, while weaker players are forced into costly financing and face shareholder activism.

23 high priority 27 medium 50 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — May 18, 2026

The 45 filings for the S&P 500 Healthcare sector reveal a sector in transition, marked by aggressive M&A (Neurocrine's $2.9B Soleno deal, Boston Scientific's $B MiRus investment) and significant capital allocation shifts (Bally's refinancing, CoreWeave's $B AI infrastructure debt). Period-over-period data shows a stark divergence: medical device and specialty pharma companies are posting strong growth (Catheter Precision +202% YoY, Bally's +28%), while diagnostics and smaller biotechs face severe revenue declines (iSpecimen -85% YoY). Insider activity is mixed, with notable director departures at Medtronic and CVS, but also new appointments at Flagstar Bank and Cellectar. Forward-looking data highlights a busy catalyst calendar with upcoming FDA decisions, shareholder votes, and clinical trial readouts. Capital allocation trends show a preference for debt-funded M&A and share buybacks, with several companies (Webster, CCEP) facing governance scrutiny over deal terms and executive compensation. Overall, the sector is experiencing a 'barbell' effect where large-cap players are consolidating and investing in high-growth areas (AI, gene therapy, TAVR), while smaller players struggle with cash burn and operational challenges.

15 high priority 30 medium 45 total filings
· daily

US Executive Compensation Proxy SEC Filings — May 18, 2026

This batch of 10 proxy filings reveals a mixed landscape for the 2026 annual meeting season, with the season, with the most actionable intelligence concentrated in T1 Energy's aggressive growth plans and Flag Ship Acquisition's existential deadline. T1 Energy stands out with strong first-year operational results—2.79 GW of solar modules manufactured and $755.3 million in net sales—but the proposal to double authorized shares from 500 million to 1 billion creates significant dilution risk for existing holders. The three Clough funds (GLQ, GLO, GLV, GLO) are purely procedural, offering no financial data or compensation insights, while Braze and SmartKem provide governance and committee activity details without quantitative performance metrics. Flag Ship Acquisition Corp presents a binary event: if the extension proposal fails, the SPAC will liquidate by June 20, 2026, rendering public rights worthless. Snowflake's Creations shows a board reduction from six to five members as Shirley Romig steps down, signaling potential governance streamlining. Overall, the lack of enriched period-over-period data in most filings limits trend analysis, but the few actionable filings that do contain operational data point to capital-intensive growth strategies and governance scrutiny as key themes for the June-July 2026 meeting window.

10 high priority 10 total filings
· daily

Global High-Priority Regulatory Events — May 18, 2026

The May 18, 2026 filing stream reveals a market bifurcated between aggressive strategic consolidation and acute financial distress. The most dominant theme is a wave of transformative M&A, led by NextEra Energy's $38B+ bid for Dominion Energy and Publicis Groupe's $2.5B acquisition of LiveRamp acquisition signal a high-conviction bet on scale in-sector consolidation and data infrastructure, respectively. However, this bullish activity is sharply contrasted by severe distress signals: Bitcoin Depot has entered bankruptcy, MTNL has disclosed a massive ₹9,339 Cr default, and several micro-cap biote-stage biotechs (ABVC, iSpecimen) are burning cash with no revenue. Period-over-period data shows a stark divergence, with LiveRamp growing revenue 9% YoY and achieving record cash flow, while OLB Group and iSpecimen saw revenues collapse 28.6% and 85.2% YoY, respectively. Insider activity ispersed across these extremes, we see tactical capital deployment via buybacks (CMS Info Systems) and insider-driven moves (TVS Motor's strategic bank stake), alongside a flurry of regulatory and insolvency proceedings in India, indicating a market that is aggressively pricing in both future growth and imminent failure.

50 high priority 50 total filings
· daily

US Earnings Financial Results SEC Filings — May 18, 2026

The 27 filings reveal a stark bifurcation in the US micro-cap landscape: revenue growth is concentrated in a few outliers (CBAK Energy +99%, Hyperscale Data + Bally's Corp + Catheter Precision), while the majority of filers show revenue declines, zero revenue, or zero revenue with zero revenue. Period-over-period data shows aggregate revenue for the 27 filers fell ~15% YoY, with 14 of 27 reporting lower or zero revenue. Margin compression is severe—CBAK Energy's gross profit collapsed 78% despite revenue doubling, and NanoVibronix swung to a gross loss. Insider activity is absent in most filings, but capital allocation signals distress: 8 companies have zero cash, 5 are funding operations solely via related-party loans, and dilution is rampant (NanoVibronix shares outstanding surged 236% in one quarter). Forward-looking data is sparse, but scheduled events (earnings calls) for Bally's Corp and Hyperscale Data offer near-term catalysts. The most actionable themes are the 'cash-zero' cohort (6 companies with zero cash) and the 'revenue growth vs. margin destruction' trade-off in CBAK Energy and Hyperscale Data.

27 high priority 27 total filings
· daily

US SEC Trading Suspension Halt Orders — May 18, 2026

Two regulatory filings on May 18, 2026 highlight contrasting listing statuses: Palatin Technologies voluntarily delists from NYSE American to transfer to Nasdaq Capital Market, maintaining its symbol PTN, while Synergy CHC Corp. faces a Nasdaq deficiency notice for failing to maintain the $1.00 bid price, with a 180-day cure period until November 11, 2026. Palatin's move is neutral, reflecting a strategic exchange transfer without financial impact, whereas Synergy's situation is negative, signaling potential delisting risk. No period-over-period comparisons, insider transactions, or forward-looking guidance were provided in either filing, limiting trend analysis. The key takeaway is the divergence in exchange health: one company proactively upgrades, the other struggles to meet listing standards. Investors should monitor Synergy's compliance efforts, including a possible reverse stock split, and Palatin's Nasdaq debut for liquidity changes.

2 high priority 2 total filings
· daily

US Corporate Distress Financial Stress SEC Filings — May 18, 2026

The May 18, 2026, filing batch reveals a bifurcated corporate landscape: while several companies are executing strategic growth moves (e.g., CoreWeave's $3.1B oversubscribed AI infrastructure financing, LiveRamp's acquisition at a 30% premium), a significant cohort is exhibiting acute financial distress. The most critical signal is Bitcoin Depot's bankruptcy filing (Item 1.03), representing a total equity wipeout for shareholders. This is compounded by a wave of dilutive equity financings (Ideal Power, Babcock & Wilcox, Faraday Future) and covenant-laden credit amendments (Inotiv, Zevia) that signal liquidity stress. A notable pattern is the surge in capital markets activity, with $4.8B+ in new debt and equity issuance across just 10 filings, indicating companies are aggressively pre-funding or restructuring ahead of potential market turbulence. Insider trading data is sparse, but the absence of insider buying during these dilutive events is a bearish signal. The overarching theme is a 'flight to quality' where well-capitalized firms (CoreWeave, NextEra) access favorable terms, while distressed names (Bitcoin Depot, Inotiv) face punitive financing and existential risk.

50 high priority 50 total filings
· daily

US Executive Officer Management Changes SEC — May 18, 2026

The May 18, 2026, filing batch reveals a broad wave of planned leadership transitions across US equities, with 44 filings covering CEO, CFO, director, and key officer changes. A dominant theme is orderly succession planning, with 15+ filings showing internal promotions or planned retirements (e.g., NextEra Energy, Builders FirstSource, Eagle Bancorp Montana), signaling strong governance and reduced disruption risk. However, notable health-related disclosures (Wyndham CEO cancer diagnosis) and director resignations (Innoviva, AiXin Life) introduce uncertainty. Shareholder dissent is a recurring pattern: 6 companies (O'Reilly Automotive, Macy's, Marriott Vacations, Ultragenyx, Celcuity, ON Semiconductor) saw >10% against votes on director elections or equity plans, indicating governance friction. Capital allocation signals are mixed—T. Rowe Price reported $1.83T in assets (retirement-heavy), while Flagstar Bank extended CEO tenure amid return to profitability. No aggregate revenue or margin trends are available as filings lack financial statements, but forward-looking data points to key catalysts: FedEx Freight separation, Kyverna CAR-T approval path, and Super Micro consulting transition. Insider activity is limited but notable: Lesaka Technologies granted 1M options to Executive Chairman options at $5.00, and Fennec Pharmaceuticals issued inducement grants at $9.75. The overall risk profile is moderate, with 6 high-risk flags (Powerdyne, Altria, CVS, Aspen Aerogels, Celcuity, Macy's) and 12 positive sentiment signals, suggesting a cautiously bullish for well-governed firms.

44 high priority 44 total filings
· daily

US Bankruptcy Chapter 11 Insolvency SEC Filings — May 18, 2026

The sole filing in today's bankruptcy intelligence stream is a comprehensive 8-K from Bitcoin Depot Inc., signaling a critical bankruptcy or receivership event (Item 1.03) combined with triggered financial obligations and executive departures. This filing represents a total equity value destruction event for shareholders, with the company—a Bitcoin ATM operator—facing likely Chapter 11 proceedings or similar restructuring. The enriched data reveals no period-over-period comparisons, insider activity, or forward-looking guidance, as the filing is a binary event disclosure rather than a periodic report. The bearish sentiment and critical risk level are fully justified, as the multiple 8-K items (1.03, 2.04, 5.02, 7.01, 9.01) indicate a comprehensive and severe financial collapse. Creditors face uncertain recovery rates, and the crypto-adjacent sector adds regulatory complexity. This is a singular, high-severity event with no portfolio-level trends to aggregate, but it serves as a stark reminder of the risks in the Bitcoin ATM and broader crypto infrastructure space.

1 high priority 1 total filings
· daily

US Corporate Board Director Changes SEC Filings — May 18, 2026

The 44 filings reveal a wave of board and C-suite changes across sectors, with notable insider departures at CVS, Hilton, and Aspen Aerogels (details missing) and planned successions at NextEra Energy, FedEx, and Builders FirstSource. Key period-over-period trends include strong shareholder support for say-on-pay at NACCO (99.7%) and Mastech (92.2%), but dissent at Macy's (78.6%) and Marriott Vacations (68.9% for equity plan). Insider activity is mixed: CEO Geoff Ballotti's health disclosure at Wyndham is a concern, while T. Rowe Price's leadership appointments signal strategic confidence. Capital allocation is stable, with no major buyback or dividend changes. The most critical development is the planned tax-free spin-off of FedEx Freight, which could unlock value. Sector themes include routine board refreshment, shareholder pushback on compensation plans, and a focus on AI and technology infrastructure appointments.

44 high priority 44 total filings
· daily

US Merger & Acquisition SEC Filings — May 18, 2026

The May 18, 2026, M&A landscape is dominated by a surge in SPAC activity, with four new IPOs (Berto, Patriot, GSR V, and the upsized Quantum Leap) collectively raising over $834 million, signaling robust appetite for blank-check vehicles despite a mixed track record. The most material event is Neurocrine Biosciences' $2.9B acquisition of Soleno Therapeutics, a high-conviction deal that closed with 88.9% shareholder tenders, adding a newly approved rare disease drug to its portfolio. However, this is contrasted by a high-risk, dilutive transaction at Quince Therapeutics, where existing shareholders are diluted to just 6.9% ownership post-merger, and a failed deal at Starry Sea Acquisition Corp., highlighting the binary nature of SPAC outcomes. A notable period-over-period trend is the shift toward operational maturity, with several SPACs (Iron Horse, Spring Valley) progressing toward definitive business combinations, while others (Quantum Leap) face going-concern warnings. Insider activity is limited but telling, with the Quince deal featuring significant PIPE investor participation ($187M) that signals external conviction despite massive dilution. The overall market implication is a bifurcated environment: capital is flowing freely into new SPACs, but execution risk remains high, and investors must discriminate between value-creating acquisitions and value-destructive structures.

16 high priority 16 total filings
· monthly

US Pre-Market SEC Filings Roundup — May 18, 2026

The overnight filing cycle from May 17-18, 2026 reveals a bifurcated landscape: significant M&A activity with premiums (LiveRamp at 30% premium, Artivion $175M acquisition) contrasts with severe financial distress in micro-caps (Bitcoin Depot bankruptcy, iSpecimen 85% revenue decline). Period comparisons show mixed revenue trends—LiveRamp grew 9% YoY while OLB Group fell 28.6% and iSpecimen collapsed 85.2%. Margin compression was evident at LiveRamp (1ppt decline) and Presidio Property Trust (swung to net loss). Equity offerings dominated capital allocation (Perma-Fix, Flux Power, LanzaTech, Estrella), while Coeur Mining executed aggressive buybacks ($69.7M). Forward-looking catalysts include FDA decisions (Outlook Therapeutics May 2026), clinical trial starts (Context Therapeutics Q3 2026), and shareholder votes (CCEP AGM May 28, Gossamer Bio restructuring). Insider trading activity was absent from enriched data, but management changes at Wyndham (CEO health disclosure) and lululemon (CEO transition) add governance angles.

22 high priority 28 medium 50 total filings
· daily

Federal Construction & Infrastructure Contracts — May 16, 2026

The single contract analyzed carries a total obligation of $544,658,997, awarded entirely to the civilian Department of State with zero defense-related activity. BL HARBERT INTERNATIONAL LLC received a definitive fixed-price contract with economic price adjustment for NEC Kinshasa construction under NAICS 236220, spanning from the 2022-09-28 award through 2029-02-19. The dominant theme is large-scale diplomatic infrastructure construction executed under full and open competition without set-asides. The highest-conviction signal is the neutral 5/10 rating on a $544.7 million award that has generated zero outlays to date. Key watch items include the $27.6 million flowing through 68 subawards and potential impacts from the economic price adjustment mechanism on a contract extending into 2029.

1 total filings
· daily

DHS Homeland Security Contracts — May 16, 2026

The May 16, 2026 period contains a single $16,409,442 obligation entirely from the civilian DHS U.S. Coast Guard, with zero defense-related awards. Lockheed Martin Corporation received the sole-source firm-fixed-price delivery order for two maritime communication controller systems supporting National Security Cutters, including non-recurring engineering and testing in Moorestown, NJ. The dominant theme is Coast Guard C5I modernization via a civilian-agency delivery order under NAICS 334290. Highest-conviction signal is neutral at 4/10 strength and 3/10 materiality. Key risk item is the high pricing risk embedded in the firm-fixed-price structure combined with a multi-year performance period and $0 outlayed to date as of the May 14, 2026 award.

1 total filings
· daily

VA Healthcare & Services Contracts — May 16, 2026

Oracle Health Government Services, Inc. received the sole $502,408,524 obligation under this VA Healthcare & Services Contracts analysis, representing 100% civilian awards with zero defense-related contracts. The Department of Veterans Affairs Technology Acquisition Center issued a firm-fixed-price delivery order on 2021-09-28 for EHRM licenses and fees under NAICS 541512 and PSC 7A21, with a potential completion date of 2027-05-16. The neutral signal (5/10 strength, 8/10 materiality) reflects a large uncompeted award to a non-small business with full obligation but zero outlays recorded to date. Highest-conviction element is the scale of this VA IT commitment for electronic health record modernization. Key watch item is the absence of any outlays despite full obligation and the 2027-05-16 end date.

1 total filings
· daily

New Federal Contractors — May 16, 2026

The four contracts represent $1,379,719,154 in total civilian obligations with zero defense-related awards. Department of State ($544.7M) and Department of Veterans Affairs ($502.4M) dominate the period, followed by Treasury IT services and a small DHS/Coast Guard delivery order. Highest-conviction signal is the bullish 7/10 rating on Lancer Information Solutions’ $316.2M firm-fixed-price Salesforce delivery order with $231.9M already outlayed. Three neutral signals reflect large unspent obligations and sole-source elements at Oracle Health and BL Harbert. Key risk is execution and outlay timing across fixed-price awards that extend through 2027-2029 with zero dollars outlayed to date on three of the four contracts.

4 total filings
· daily

Significant Contract Modifications ($10M+) — May 16, 2026

Four civilian contracts totaling $1,379,719,154 in obligations were awarded between 2021 and 2026 with zero defense-related activity. The Department of State ($544.7M) and Department of Veterans Affairs ($502.4M) dominate by value, followed by Treasury ($316.2M) and DHS Coast Guard ($16.4M). The highest-conviction signal is the bullish $316.2M firm-fixed-price delivery order to Lancer Information Solutions for Salesforce IT services supporting Treasury Departmental Offices. Key risk or watch item is the $0 outlayed to date on the two largest awards to BL Harbert International and Oracle Health Government Services despite full obligation.

4 total filings
· daily

Contract Deobligations Alert — May 16, 2026

The four contracts represent $1,379,719,154 in total obligations, all civilian with zero defense awards. Dominant themes are large-scale IT modernization at the Department of Veterans Affairs and Department of the Treasury alongside infrastructure work for the Department of State. Highest-conviction signal is the $316,242,190 firm-fixed-price delivery order to Lancer Information Solutions, LLC for Treasury Salesforce services, supported by $231.9M already outlayed. Oracle Health Government Services, Inc. holds the second-largest award at $502,408,524 for VA EHRM licenses with no outlays to date. Key risk centers on $0 outlays across the $1.05B combined obligations to BL Harbert International LLC and Oracle despite full funding and long performance periods through 2029 and 2027.

4 total filings
· daily

Contract Option Exercises — May 16, 2026

Four civilian agency contract awards totaling $1,379,719,154 were executed with zero defense-related obligations. The dominant theme is IT services and enterprise modernization across the Department of Veterans Affairs, Department of the Treasury, and Department of State, with a smaller maritime communications award to Lockheed Martin from DHS. The highest-conviction signal is the bullish $316 million Lancer Information Solutions firm-fixed-price delivery order for Salesforce services supporting Treasury Departmental Offices. BL Harbert International received the single largest obligation at $544.7 million for NEC Kinshasa construction. Key watch item is zero outlays recorded to date on the three largest awards despite full obligation, signaling potential execution or invoicing delays.

4 total filings
· daily

Federal IT & Cybersecurity Contracts — May 16, 2026

The two contracts represent $818,650,715 in total civilian obligations with zero defense-related awards. Department of Veterans Affairs and Department of the Treasury dominate spending through EHRM licenses and Salesforce IT services. Highest-conviction signal is the bullish 7/10 rating on Lancer Information Solutions' $316,242,190 Treasury award, which already shows $231,887,389 in outlays under full-and-open competition. Oracle Health Government Services' $502,408,524 VA firm-fixed-price award remains neutral due to zero outlays to date and lack of competition. Key watch item is tracking cumulative outlays and any 2027 end-date modifications across both vehicles.

2 total filings